Cargando…
Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: retrospective study
INTRODUCTION: The impact of pectoralis muscle mass index (PMI) on cardiac events is not well studied in cancer patients, especially in those who have received chemotherapy with high potential cardiac toxicity such as anthracyclines. METHODS: Individuals aged ≥18 years with a diagnosis of breast canc...
Autores principales: | Toama, Wael, Wiederin, Jason, Shanley, Ryan, Jewett, Patricia, Gu, Christina, Shenoy, Chetan, Nijjar, Prabhjot S., Blaes, Anne H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281070/ https://www.ncbi.nlm.nih.gov/pubmed/35831837 http://dx.doi.org/10.1186/s12885-022-09882-w |
Ejemplares similares
-
Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015) -
Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance
por: Huang, Hans, et al.
Publicado: (2017) -
Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
por: Meiners, Becky, et al.
Publicado: (2018) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy
por: Hung, Olivia Y, et al.
Publicado: (2015)